Recombinant Perisphaeria aff. bicolor Periviscerokinin-1

What is Periviscerokinin-1 and how does it relate to the CAPA gene family?

Periviscerokinin-1 (PVK-1) is a member of the cardioacceleratory peptide 2b (CAP2b)/periviscerokinin (PVK) neuropeptide family encoded by the CAPA gene. In arthropods, these neuropeptides play critical roles in regulating myotropic and diuretic activities. The CAPA/PVK peptides are evolutionarily conserved across the phylum Arthropoda, with related peptides identified in multiple species including ticks such as Ixodes ricinus, Ixodes scapularis, and Rhipicephalus microplus . Research indicates that these peptides and their cognate receptors serve as integrative regulators of physiological processes in Ecdysozoa, particularly in feeding, reproduction, and survival mechanisms.

How is Recombinant Perisphaeria aff. bicolor Periviscerokinin-1 produced for research purposes?

Recombinant Perisphaeria aff. bicolor Periviscerokinin-1 is typically produced through heterologous expression systems. The process generally follows these steps:

• Isolation and sequencing of the PVK-1 gene from Perisphaeria aff. bicolor tissues

• Cloning the gene into an expression vector

• Transformation of the construct into an appropriate host (commonly E. coli, yeast, or insect cell lines)

• Induction of protein expression under controlled conditions

• Purification using chromatographic techniques (affinity, ion-exchange, or size-exclusion)

• Confirmation of identity through mass spectrometry, similar to methods used for other bioactive peptides identified via ultra-high resolution Electro-Spray Ionization-Mass Spectrometry (ESI-MS)

This approach mirrors techniques used for other arthropod neuropeptides while maintaining the specific sequence integrity of the target peptide.

What are the structural characteristics of Periviscerokinin-1?

Periviscerokinin-1 is a short peptide characterized by:

• A C-terminal PRV (proline-arginine-valine) or PRXamide motif typical of the CAPA/PVK family

• Conservation of key amino acid residues that are essential for receptor binding

• A three-dimensional structure that facilitates interaction with its cognate G-protein-coupled receptor

• Molecular similarities to other bioactive peptides found in arthropod secretions

The peptide's structural configuration is critical for its biological activity, particularly in binding to the periviscerokinin receptor that has been identified and characterized in species like R. microplus and I. scapularis .

What experimental approaches are most effective for studying Periviscerokinin-1 receptor signaling pathways?

To effectively study Periviscerokinin-1 receptor signaling pathways, researchers should consider multiple complementary approaches:

• RNA interference (RNAi): Using dsRNA targeting the receptor (similar to the Rhimi-CAP 2bR silencing approach) to evaluate physiological impacts. This technique has successfully demonstrated the importance of periviscerokinin receptors in R. microplus, where silencing resulted in increased female mortality, decreased weight, and reduced reproductive efficiency .

• Receptor expression profiling: Quantitative reverse-transcriptase PCR (qRT-PCR) to assess receptor expression across developmental stages and tissues. Data from R. microplus studies showed receptor expression throughout all developmental stages .

• Calcium mobilization assays: For measuring receptor activation in transfected cells expressing the receptor.

• CRISPR-Cas9 genome editing: For generating receptor knockout models to study long-term physiological consequences.

• Pharmacological approaches: Using selective agonists and antagonists to characterize signaling pathways downstream of receptor activation.

The combination of these approaches provides comprehensive insights into receptor function and signaling mechanisms.

How do post-translational modifications affect the biological activity of Periviscerokinin-1?

Post-translational modifications (PTMs) significantly influence Periviscerokinin-1's biological activity through:

• C-terminal amidation: Essential for receptor recognition and binding affinity, as seen in other members of the CAP2b/PVK family.

• Disulfide bond formation: May affect tertiary structure and stability, though the specific pattern varies among different species.

• Glycosylation: Potential impact on peptide half-life in circulation and receptor interaction kinetics.

• Proteolytic processing: The activation of precursor proteins into bioactive peptides is a critical regulatory step, similar to processing in other bioactive peptides found in amphibian skin secretions .

To accurately study PTMs in Periviscerokinin-1, mass spectrometry techniques are indispensable, allowing for precise molecular characterization similar to approaches used for analyzing other bioactive peptides in natural secretions.

What are the key differences between Perisphaeria aff. bicolor Periviscerokinin-1 and periviscerokinin peptides from other arthropod species?

Comparative analyses reveal several important differences:

These differences contribute to species-specific physiological responses and may explain variations in receptor activation profiles across arthropod taxa.

What is the optimal protocol for purifying recombinant Periviscerokinin-1 while maintaining its biological activity?

The optimal purification protocol for maintaining biological activity includes:

• Expression optimization:

  • Use of insect cell expression systems (Sf9 or High Five cells) for proper folding and post-translational modifications

  • Temperature reduction during induction (16-18°C) to minimize inclusion body formation

• Extraction conditions:

  • Gentle lysis using non-ionic detergents

  • Inclusion of protease inhibitors to prevent degradation

  • Maintaining pH between 6.5-7.5 to preserve structural integrity

• Purification steps:

  • Initial capture using affinity chromatography (His-tag or GST-tag)

  • Intermediate purification using ion-exchange chromatography

  • Polishing step with size exclusion chromatography

  • All steps performed at 4°C to minimize degradation

• Activity preservation:

  • Addition of stabilizing agents (5-10% glycerol)

  • Lyophilization in the presence of cryoprotectants

  • Storage at -80°C in small aliquots to avoid freeze-thaw cycles

This protocol draws upon general principles for maintaining the activity of bioactive peptides while addressing the specific characteristics of periviscerokinin family peptides.

How can RNA interference be effectively applied to study Periviscerokinin-1 receptor function in arthropod models?

RNA interference can be effectively applied through the following methodological approach:

• dsRNA design:

  • Target conserved regions of the receptor sequence

  • Design multiple dsRNAs targeting different regions (as demonstrated in R. microplus studies with three different dsRNAs: ds680-805, ds956-1109, and ds1102-1200)

  • Ensure specificity using BLAST analysis to avoid off-target effects

  • Optimal length of 300-500 bp for efficient silencing

• Delivery methods:

  • Microinjection into the hemocoel (most reliable method)

  • Feeding (encapsulated dsRNA)

  • Soaking (for smaller specimens)

  • Topical application (lipid-based transfection reagents)

• Validation of silencing:

  • Quantitative reverse-transcriptase PCR to confirm reduction in target mRNA levels

  • Western blotting to verify protein reduction when antibodies are available

  • Include appropriate controls (non-injected and dsRNA targeting non-arthropod genes like beta-lactamase)

• Phenotypic assessment:

  • Systematically analyze survival, feeding, reproduction, and development

  • Compare results to multiple control groups (as done in the R. microplus studies)

  • Document all abnormal phenotypes with statistical analysis

This methodology has proven effective in revealing the physiological importance of periviscerokinin receptors, as demonstrated in R. microplus where silencing resulted in significant effects on female tick survival, weight, egg mass, incubation period, and egg hatching .

What analytical techniques are most appropriate for characterizing the binding kinetics between Periviscerokinin-1 and its receptor?

To thoroughly characterize binding kinetics between Periviscerokinin-1 and its receptor, the following analytical techniques are recommended:

• Surface Plasmon Resonance (SPR):

  • Real-time analysis of association and dissociation rates

  • Determination of KD, kon, and koff values

  • No requirement for ligand labeling

  • Example protocol: Immobilize purified receptor on CM5 chip, inject various concentrations of synthetic or recombinant Periviscerokinin-1, analyze using Biacore or similar systems

• Isothermal Titration Calorimetry (ITC):

  • Direct measurement of binding thermodynamics

  • Provides enthalpy (ΔH), entropy (ΔS), and Gibbs free energy (ΔG) values

  • Label-free analysis in solution

• Fluorescence-based techniques:

  • Fluorescence Resonance Energy Transfer (FRET)

  • Fluorescence Polarization (FP)

  • Time-resolved FRET for improved sensitivity

• Radioligand binding assays:

  • Scatchard analysis for binding site quantification

  • Competition binding studies with unlabeled peptides

• Bioluminescence Resonance Energy Transfer (BRET):

  • Especially useful for monitoring receptor-ligand interactions in living cells

  • Provides information on real-time dynamics and internalization

These techniques should be used in combination to develop a complete kinetic and thermodynamic profile of the peptide-receptor interaction, which is essential for understanding the pharmacological basis of Periviscerokinin-1 activity.

How can Periviscerokinin-1 receptor systems be exploited for arthropod pest control strategies?

The Periviscerokinin-1 receptor system presents several promising avenues for pest control development:

• Receptor antagonists: Development of small molecules or peptide mimetics that block the receptor could disrupt critical physiological processes. Research in R. microplus demonstrated that loss of receptor function through RNAi was detrimental to female ticks, suggesting that antagonistic molecules targeting this signaling system could produce similar effects and serve as promising tick control agents .

• RNA interference-based biopesticides: Formulation of dsRNA targeting the periviscerokinin receptor for application as sprays or baits. This approach could be particularly effective since Rhimi-CAP 2bR silencing was associated with increased female mortality and decreased reproductive capacity in ticks .

• Receptor agonist overdose: Development of highly potent agonists that cause physiological disruption through overstimulation of natural pathways.

• Chimeric toxins: Creation of fusion proteins combining Periviscerokinin-1 with known insecticidal toxins for enhanced targeting specificity.

• Transgenic approaches: Engineering crop plants to express dsRNA targeting the receptor in pest species.

These approaches represent targeted strategies that could potentially minimize environmental impact while effectively controlling arthropod pests that cause significant agricultural and public health concerns.

What is the current evidence for cross-reactivity between Perisphaeria aff. bicolor Periviscerokinin-1 and receptors from other arthropod species?

Current evidence regarding cross-reactivity includes:

This pattern of cross-reactivity appears to follow phylogenetic relationships, with greater conservation of response among more closely related species. The observed conservation of receptor activation across some arthropod taxa suggests potential for developing broad-spectrum control agents, while the specificity observed in others provides opportunities for targeted approaches.

How does Periviscerokinin-1 compare functionally to other CAPA peptides in physiological studies?

Functional comparisons between Periviscerokinin-1 and other CAPA peptides reveal important physiological distinctions:

Studies of periviscerokinin receptors in ticks demonstrate that these signaling systems are associated with critical physiological processes including feeding, reproduction, and survival, as evidenced by the significant effects observed when receptor function was disrupted in R. microplus females . This pattern of functional diversification while maintaining structural similarities is consistent with evolutionary divergence within the CAPA peptide family.

What genomic approaches could accelerate the discovery of novel periviscerokinin peptides across arthropod taxa?

Innovative genomic approaches to accelerate periviscerokinin peptide discovery include:

• Comparative genomics pipelines:

  • Systematic scanning of arthropod genomes for CAPA gene homologs

  • Phylogenetic analysis to identify evolutionary patterns in peptide diversification

  • Development of machine learning algorithms for recognition of cryptic CAPA-related genes

• Transcriptomics-guided discovery:

  • RNA-Seq analysis of neuropeptide-producing tissues across developmental stages

  • Single-cell transcriptomics to identify specific CAPA-expressing cell populations

  • Differential expression analysis under varying physiological conditions

• Peptidomics integration:

  • Mass spectrometry-based peptidomics coupled with genomic data

  • De novo sequencing of neurohormone extracts

  • Leveraging ultra-high resolution Electro-Spray Ionization-Mass Spectrometry (ESI-MS) techniques similar to those used for bioactive peptide identification in other species

• CRISPR-based functional genomics:

  • Systematic editing of putative CAPA genes to confirm function

  • Creation of reporter lines for visualization of expression patterns

• Bioinformatics resources development:

  • Creation of specialized databases for arthropod neuropeptides

  • Development of prediction tools for post-translational modifications

These approaches would significantly expand our understanding of periviscerokinin diversity and potentially identify novel peptides with unique pharmacological properties.

What are the challenges and potential solutions in developing stable analogs of Periviscerokinin-1 for research applications?

The development of stable Periviscerokinin-1 analogs faces several challenges with corresponding potential solutions:

Addressing these challenges through rational design approaches has precedent in the development of other bioactive peptide analogs, including those derived from amphibian skin secretions that have shown potential as therapeutic agents .

How might systems biology approaches enhance our understanding of Periviscerokinin-1 signaling networks in arthropods?

Systems biology approaches offer powerful frameworks for understanding complex Periviscerokinin-1 signaling networks:

• Multi-omics integration:

  • Combining transcriptomics, proteomics, and metabolomics data

  • Temporal analysis of cellular responses following receptor activation

  • Correlation of receptor expression patterns with physiological states

• Computational modeling:

  • Development of mathematical models of receptor-mediated signaling cascades

  • Simulation of system responses under varying conditions

  • Prediction of network perturbations and compensatory mechanisms

• Protein-protein interaction networks:

  • Identification of receptor-interacting proteins using proximity labeling

  • Characterization of signaling complexes through co-immunoprecipitation

  • Construction of interactome maps specific to CAPA receptor signaling

• In vivo imaging:

  • Real-time visualization of signaling using fluorescent biosensors

  • Whole-organism imaging of physiological responses

  • Correlation of cellular signaling with behavioral outputs

• Cross-species comparison of signaling networks:

  • Comparative analysis of network architecture across arthropod taxa

  • Identification of conserved and divergent signaling modules

  • Evolutionary analysis of network complexity and robustness

The integration of these approaches would provide unprecedented insights into the physiological significance of Periviscerokinin-1 signaling, building upon the foundational understanding established through studies such as those on the periviscerokinin receptor in R. microplus , where receptor function was demonstrated to be critical for female feeding, reproduction, and survival.